Checkpoint Therapeutics Inc.

05/13/2022 | Press release | Distributed by Public on 05/13/2022 06:42

Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Cosibelimab from the European Medicines Agency and U.K. Medicines & Healthcare Products Regulatory[...]